Type 4 phosphodiesterase inhibitor suppresses experimental bladder inflammation

BJU International

Volumn 102, Issue 10, 2008, Pages 1472-1476

  Kitta, Takeya ^a   Tanaka, Hiroshi ^a   Mitsui, Takahiko ^a   Moriya, Kimihiko ^a   Nonomura, Katsuya ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

c fos; Inflammation; Phosphodiesterase type 4; Rats

Indexed keywords

4 (3 CHLOROPHENYL) 1,7 DIETHYLPYRIDO[2,3 D]PYRIMIDIN 2(1H) ONE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER BLEEDING; BLADDER CAPACITY; BLADDER FUNCTION; BLADDER INJURY; CELL INFILTRATION; CONTROLLED STUDY; CYSTALGIA; CYSTITIS; CYSTOMETRY; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; EDEMA; FEMALE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUMBOSACRAL SPINE; NERVE CELL; NOCICEPTION; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URINE VOLUME; URODYNAMICS; WISTAR RAT;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYSTITIS, INTERSTITIAL; FEMALE; HYDROCHLORIC ACID; PHOSPHODIESTERASE INHIBITORS; PYRIDINES; PYRIMIDINONES; RATS; RATS, WISTAR; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 54949146848     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07662.x     Document Type: Article

References (18)

1. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988 140 : 203 6
2. Theoharides TC. Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs 2007 67 : 215 35
3. Westropp JL, Buffington CA. In vivo models of interstitial cystitis. J Urol 2002 167 : 694 702
4. Rivas DA, Chancellor MB, Shupp-Byrne S, Shenot PJ, McHugh K, McCue P. Molecular marker for development of interstitial cystitis in rat model: isoactin gene expression. J Urol 1997 157 : 1937 40
5. Banner KH, Page CP. Anti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors. Clin Exp Allergy 1996 26 (Suppl. 2 9
6. Fawcett L, Baxendale R, Stacey P et al. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 2000 97 : 3702 7
7. Teixeira MM, Gristwood RW, Cooper N, Hellewell PG. Phosphodiesterase (PDE) 4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 1997 18 : 164 71
8. Torphy TJ, Barnette MS, Underwood DC et al. Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. Pulm Pharmacol Ther 1999 12 : 131 5
9. Aoki M, Kobayashi M, Ishikawa J et al. A novel phosphodiesterase type 4 inhibitor, YM976 (4-(3-chlorophenyl) -1,7-diethylpyrido[2,3-d]pyrimidin-2(1H)- one), with little emetogenic activity. J Pharmacol Exp Ther 2000 295 : 255 60
10. Aoki M, Fukunaga M, Kitagawa M et al. Effect of a novel anti-inflammatory compound, YM976, on antigen-induced eosinophil infiltration into the lungs in rats, mice, and ferrets. J Pharmacol Exp Ther 2000 295 : 1149 55
11. Bjorling DE, Jerde TJ, Zine MJ, Busser BW, Saban MR, Saban R. Mast cells mediate the severity of experimental cystitis in mice. J Urol 1999 162 : 231 6
12. Birder LA, de Groat WC. Increased c-fos expression in spinal neurons after irritation of the lower urinary tract in the rat. J Neurosci 1992 12 : 4878 89
13. Luber-Narod J, Austin-Ritchie T, Banner B et al. Experimental autoimmune cystitis in the Lewis rat: a potential animal model for interstitial cystitis. Urol Res 1996 24 : 367 73
14. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 1990 143 : 139 42
15. Schudt C, Tenor H, Hatzelmann A. PDE isoenzymes as targets for anti-asthma drugs. Eur Respir J 1995 8 : 1179 83
16. Banner KH, Page CP. Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995 8 : 996 1000
17. Aoki M, Fukunaga M, Sugimoto T et al. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor. J Pharmacol Exp Ther 2001 298 : 1142 9
18. Mitsui T, Kakizaki H, Matsuura S, Ameda K, Yoshioka M, Koyanagi T. Afferent fibers of the hypogastric nerves are involved in the facilitating effects of chemical bladder irritation in rats. J Neurophysiol 2001 86 : 2276 84